Should I buy Accenture (ACN) stock or is it too late?
⭐ The most reliable of them, either direction: Truist Securities — 74% of its targets hit on this sector (203 calls tested). It aims for $150 (-20 %), call made on June 23, 2026, maturing on June 23, 2027 (66 d ago).
Firm-by-firm track record on Accenture
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Susquehanna | 86 % | +19.7 % | 7 | $140 -25% |
| Citigroup | 67 % | +15.4 % | 30 | $190 +1% |
| Morgan Stanley | 61 % | +14.3 % | 31 | $130 -31% |
| Stifel | 69 % | +11.2 % | 26 | $270 +44% |
| RBC Capital | 70 % | +10.8 % | 20 | $175 -7% |
| TD Cowen | 44 % | +7.6 % | 16 | $151 -19% |
| JP Morgan | 65 % | +6.8 % | 26 | $201 +7% |
| B of A Securities | 40 % | -3.6 % | 20 | $388 +107% |
✅ Reasons to believe
- 63% of analysts rate it a buy (Buy consensus, 16 ratings) — a sign of market conviction.
- The most reliable firm on ACN, Wells Fargo (100% hit rate, 4 scored calls), targets $194 (call made on July 20, 2026, maturing on July 20, 2027) (+4%) in its most recent call, and $251 (call made on October 22, 2025, maturing on October 22, 2026) (+34%) in the one coming due soonest.
- 5 analysts rated reliable (≥55% hit rate, beat their sector) are bullish on the stock.
- Pays a dividend (2.4% yield) — regular income on top of potential upside.
- Reasonable valuation (P/E ~14) relative to its sector.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 16 ratings, 6 are neutral.
- Limited upside: the median target is only +2% from the current price.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- Volatile stock: sharp swings — including steep drops — are part of its profile.
The analyst consensus on ACN
Median target $192 (+2%) · 16 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Accenture now?
We won't decide for you. The facts: 63% of analysts rate it a buy, median target $192 (+2%), and Wells Fargo (most reliable on ACN, 100%) targets $194. Weigh that against valuation (P/E ~14) and volatility. This is not personalized advice.
Is it too late to invest in Accenture?
The stated upside is small: the median target ($192) sits just +2% from the price ($187) (most reliable on ACN: Wells Fargo, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Accenture still worth investing in?
It depends on the gap between the price ($187) and its estimated value: analysts target $192 on median (+2%), with 63% buys (most reliable on ACN: Wells Fargo, 100%). Cross-check with their real reliability on ACN and the cautions above. Information, not advice.
What's the main risk in buying ACN?
The consensus is not unanimous: of 16 ratings, 6 are neutral.
→ Go deeper: the full Accenture profile (consensus, analyst reliability, price target, performance).